Table of Content

1 Immune Drugs Market Overview
1.1 Immune Drugs Product Overview
1.2 Immune Drugs Market Segment by Type
1.2.1 Immune Boosting Drugs
1.2.2 Immunosuppressant Drugs
1.3 Global Immune Drugs Market Size by Type
1.3.1 Global Immune Drugs Market Size Overview by Type (2024-2034)
1.3.2 Global Immune Drugs Historic Market Size Review by Type (2024-2024)
1.3.3 Global Immune Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Immune Drugs Sales Breakdown by Type (2024-2024)
1.4.2 Europe Immune Drugs Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Immune Drugs Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Immune Drugs Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Immune Drugs Sales Breakdown by Type (2024-2024)
2 Global Immune Drugs Market Competition by Company
2.1 Global Top Players by Immune Drugs Sales (2024-2024)
2.2 Global Top Players by Immune Drugs Revenue (2024-2024)
2.3 Global Top Players by Immune Drugs Price (2024-2024)
2.4 Global Top Manufacturers Immune Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Immune Drugs Market Competitive Situation and Trends
2.5.1 Immune Drugs Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Immune Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Immune Drugs Market
2.8 Key Manufacturers Immune Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Immune Drugs Status and Outlook by Region
3.1 Global Immune Drugs Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Immune Drugs Historic Market Size by Region
3.2.1 Global Immune Drugs Sales in Volume by Region (2024-2024)
3.2.2 Global Immune Drugs Sales in Value by Region (2024-2024)
3.2.3 Global Immune Drugs Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Immune Drugs Forecasted Market Size by Region
3.3.1 Global Immune Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Immune Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Immune Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Immune Drugs by Application
4.1 Immune Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Surgery Center
4.1.4 Others
4.2 Global Immune Drugs Market Size by Application
4.2.1 Global Immune Drugs Market Size Overview by Application (2024-2034)
4.2.2 Global Immune Drugs Historic Market Size Review by Application (2024-2024)
4.2.3 Global Immune Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Immune Drugs Sales Breakdown by Application (2024-2024)
4.3.2 Europe Immune Drugs Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Immune Drugs Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Immune Drugs Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Immune Drugs Sales Breakdown by Application (2024-2024)
5 North America Immune Drugs by Country
5.1 North America Immune Drugs Historic Market Size by Country
5.1.1 North America Immune Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Immune Drugs Sales in Volume by Country (2024-2024)
5.1.3 North America Immune Drugs Sales in Value by Country (2024-2024)
5.2 North America Immune Drugs Forecasted Market Size by Country
5.2.1 North America Immune Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Immune Drugs Sales in Value by Country (2024-2034)
6 Europe Immune Drugs by Country
6.1 Europe Immune Drugs Historic Market Size by Country
6.1.1 Europe Immune Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Immune Drugs Sales in Volume by Country (2024-2024)
6.1.3 Europe Immune Drugs Sales in Value by Country (2024-2024)
6.2 Europe Immune Drugs Forecasted Market Size by Country
6.2.1 Europe Immune Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Immune Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Immune Drugs by Region
7.1 Asia-Pacific Immune Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Immune Drugs Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Immune Drugs Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Immune Drugs Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Immune Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Immune Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Immune Drugs Sales in Value by Region (2024-2034)
8 Latin America Immune Drugs by Country
8.1 Latin America Immune Drugs Historic Market Size by Country
8.1.1 Latin America Immune Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Immune Drugs Sales in Volume by Country (2024-2024)
8.1.3 Latin America Immune Drugs Sales in Value by Country (2024-2024)
8.2 Latin America Immune Drugs Forecasted Market Size by Country
8.2.1 Latin America Immune Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Immune Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Immune Drugs by Country
9.1 Middle East and Africa Immune Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Immune Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Immune Drugs Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Immune Drugs Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Immune Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Immune Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Immune Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Antares Pharma, Inc.
10.1.1 Antares Pharma, Inc. Company Information
10.1.2 Antares Pharma, Inc. Introduction and Business Overview
10.1.3 Antares Pharma, Inc. Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Antares Pharma, Inc. Immune Drugs Products Offered
10.1.5 Antares Pharma, Inc. Recent Development
10.2 UCB
10.2.1 UCB Company Information
10.2.2 UCB Introduction and Business Overview
10.2.3 UCB Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.2.4 UCB Immune Drugs Products Offered
10.2.5 UCB Recent Development
10.3 Incyte
10.3.1 Incyte Company Information
10.3.2 Incyte Introduction and Business Overview
10.3.3 Incyte Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Incyte Immune Drugs Products Offered
10.3.5 Incyte Recent Development
10.4 GSK
10.4.1 GSK Company Information
10.4.2 GSK Introduction and Business Overview
10.4.3 GSK Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.4.4 GSK Immune Drugs Products Offered
10.4.5 GSK Recent Development
10.5 Takeda
10.5.1 Takeda Company Information
10.5.2 Takeda Introduction and Business Overview
10.5.3 Takeda Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Takeda Immune Drugs Products Offered
10.5.5 Takeda Recent Development
10.6 3S Bio
10.6.1 3S Bio Company Information
10.6.2 3S Bio Introduction and Business Overview
10.6.3 3S Bio Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.6.4 3S Bio Immune Drugs Products Offered
10.6.5 3S Bio Recent Development
10.7 Horizo​​n Therapeutics
10.7.1 Horizo​​n Therapeutics Company Information
10.7.2 Horizo​​n Therapeutics Introduction and Business Overview
10.7.3 Horizo​​n Therapeutics Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Horizo​​n Therapeutics Immune Drugs Products Offered
10.7.5 Horizo​​n Therapeutics Recent Development
10.8 Bristol-Myers Squibb (BMS
10.8.1 Bristol-Myers Squibb (BMS Company Information
10.8.2 Bristol-Myers Squibb (BMS Introduction and Business Overview
10.8.3 Bristol-Myers Squibb (BMS Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Bristol-Myers Squibb (BMS Immune Drugs Products Offered
10.8.5 Bristol-Myers Squibb (BMS Recent Development
10.9 Astellas
10.9.1 Astellas Company Information
10.9.2 Astellas Introduction and Business Overview
10.9.3 Astellas Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Astellas Immune Drugs Products Offered
10.9.5 Astellas Recent Development
10.10 Eli Lilly
10.10.1 Eli Lilly Company Information
10.10.2 Eli Lilly Introduction and Business Overview
10.10.3 Eli Lilly Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Eli Lilly Immune Drugs Products Offered
10.10.5 Eli Lilly Recent Development
10.11 Mitsubishi Tanabe Pharma
10.11.1 Mitsubishi Tanabe Pharma Company Information
10.11.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.11.3 Mitsubishi Tanabe Pharma Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Mitsubishi Tanabe Pharma Immune Drugs Products Offered
10.11.5 Mitsubishi Tanabe Pharma Recent Development
10.12 Biogen
10.12.1 Biogen Company Information
10.12.2 Biogen Introduction and Business Overview
10.12.3 Biogen Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Biogen Immune Drugs Products Offered
10.12.5 Biogen Recent Development
10.13 Pfizer
10.13.1 Pfizer Company Information
10.13.2 Pfizer Introduction and Business Overview
10.13.3 Pfizer Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Pfizer Immune Drugs Products Offered
10.13.5 Pfizer Recent Development
10.14 Sanofi
10.14.1 Sanofi Company Information
10.14.2 Sanofi Introduction and Business Overview
10.14.3 Sanofi Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Sanofi Immune Drugs Products Offered
10.14.5 Sanofi Recent Development
10.15 Roche
10.15.1 Roche Company Information
10.15.2 Roche Introduction and Business Overview
10.15.3 Roche Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Roche Immune Drugs Products Offered
10.15.5 Roche Recent Development
10.16 Novartis
10.16.1 Novartis Company Information
10.16.2 Novartis Introduction and Business Overview
10.16.3 Novartis Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Novartis Immune Drugs Products Offered
10.16.5 Novartis Recent Development
10.17 Johnson & Johnson (J&J)
10.17.1 Johnson & Johnson (J&J) Company Information
10.17.2 Johnson & Johnson (J&J) Introduction and Business Overview
10.17.3 Johnson & Johnson (J&J) Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Johnson & Johnson (J&J) Immune Drugs Products Offered
10.17.5 Johnson & Johnson (J&J) Recent Development
10.18 Amgen
10.18.1 Amgen Company Information
10.18.2 Amgen Introduction and Business Overview
10.18.3 Amgen Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Amgen Immune Drugs Products Offered
10.18.5 Amgen Recent Development
10.19 Abbvi
10.19.1 Abbvi Company Information
10.19.2 Abbvi Introduction and Business Overview
10.19.3 Abbvi Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Abbvi Immune Drugs Products Offered
10.19.5 Abbvi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Immune Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Immune Drugs Industrial Chain Analysis
11.4 Immune Drugs Market Dynamics
11.4.1 Immune Drugs Industry Trends
11.4.2 Immune Drugs Market Drivers
11.4.3 Immune Drugs Market Challenges
11.4.4 Immune Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Immune Drugs Distributors
12.3 Immune Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Immune Boosting Drugs
Table 2. Major Company of Immunosuppressant Drugs
Table 3. Global Immune Drugs Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Immune Drugs Sales by Type (2024-2024) & (K Units)
Table 5. Global Immune Drugs Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Immune Drugs Sales by Type (2024-2024) & (US& Million)
Table 7. Global Immune Drugs Market Share in Value by Type (2024-2024)
Table 8. Global Immune Drugs Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Immune Drugs Sales by Type (2024-2034) & (K Units)
Table 10. Global Immune Drugs Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Immune Drugs Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Immune Drugs Sales Market Share in Value by Type (2024-2034)
Table 13. Global Immune Drugs Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Immune Drugs Sales by Type (2024-2024) & (K Units)
Table 15. North America Immune Drugs Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Immune Drugs Sales (K Units) by Type (2024-2024)
Table 17. Europe Immune Drugs Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Immune Drugs Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Immune Drugs Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Immune Drugs Sales (K Units) by Type (2024-2024)
Table 21. Latin America Immune Drugs Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Immune Drugs Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Immune Drugs Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Immune Drugs Sales by Company (2024-2024) & (K Units)
Table 25. Global Immune Drugs Sales Share by Company (2024-2024)
Table 26. Global Immune Drugs Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Immune Drugs Revenue Share by Company (2024-2024)
Table 28. Global Market Immune Drugs Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Immune Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Immune Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Drugs as of 2022)
Table 32. Date of Key Manufacturers Enter into Immune Drugs Market
Table 33. Key Manufacturers Immune Drugs Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Immune Drugs Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Immune Drugs Sales by Region (2024-2024) & (K Units)
Table 37. Global Immune Drugs Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Immune Drugs Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Immune Drugs Sales Market Share in Value by Region (2024-2024)
Table 40. Global Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Immune Drugs Sales by Region (2024-2034) & (K Units)
Table 42. Global Immune Drugs Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Immune Drugs Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Immune Drugs Sales Market Share in Value by Region (2024-2034)
Table 45. Global Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Immune Drugs Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Immune Drugs Sales by Application (2024-2024) & (K Units)
Table 48. Global Immune Drugs Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Immune Drugs Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Immune Drugs Sales Market Share in Value by Application (2024-2024)
Table 51. Global Immune Drugs Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Immune Drugs Sales by Application (2024-2034) & (K Units)
Table 53. Global Immune Drugs Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Immune Drugs Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Immune Drugs Sales Market Share in Value by Application (2024-2034)
Table 56. Global Immune Drugs Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Immune Drugs Sales by Application (2024-2024) (K Units)
Table 58. North America Immune Drugs Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Immune Drugs Sales by Application (2024-2024) (K Units)
Table 60. Europe Immune Drugs Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Immune Drugs Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Immune Drugs Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Immune Drugs Sales by Application (2024-2024) (K Units)
Table 64. Latin America Immune Drugs Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Immune Drugs Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Immune Drugs Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Immune Drugs Sales by Country (2024-2024) & (K Units)
Table 68. North America Immune Drugs Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Immune Drugs Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Immune Drugs Sales Market Share in Value by Country (2024-2024)
Table 71. North America Immune Drugs Sales by Country (2024-2034) & (K Units)
Table 72. North America Immune Drugs Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Immune Drugs Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Immune Drugs Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Immune Drugs Sales by Country (2024-2024) & (K Units)
Table 76. Europe Immune Drugs Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Immune Drugs Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Immune Drugs Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Immune Drugs Sales by Country (2024-2034) & (K Units)
Table 80. Europe Immune Drugs Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Immune Drugs Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Immune Drugs Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Immune Drugs Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Immune Drugs Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Immune Drugs Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Immune Drugs Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Immune Drugs Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Immune Drugs Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Immune Drugs Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Immune Drugs Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Immune Drugs Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Immune Drugs Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Immune Drugs Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Immune Drugs Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Immune Drugs Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Immune Drugs Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Immune Drugs Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Immune Drugs Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Immune Drugs Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Immune Drugs Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Immune Drugs Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Immune Drugs Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Immune Drugs Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Immune Drugs Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Immune Drugs Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Immune Drugs Sales Market Share in Value by Country (2024-2034)
Table 107. Antares Pharma, Inc. Company Information
Table 108. Antares Pharma, Inc. Introduction and Business Overview
Table 109. Antares Pharma, Inc. Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Antares Pharma, Inc. Immune Drugs Product
Table 111. Antares Pharma, Inc. Recent Development
Table 112. UCB Company Information
Table 113. UCB Introduction and Business Overview
Table 114. UCB Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. UCB Immune Drugs Product
Table 116. UCB Recent Development
Table 117. Incyte Company Information
Table 118. Incyte Introduction and Business Overview
Table 119. Incyte Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Incyte Immune Drugs Product
Table 121. Incyte Recent Development
Table 122. GSK Company Information
Table 123. GSK Introduction and Business Overview
Table 124. GSK Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. GSK Immune Drugs Product
Table 126. GSK Recent Development
Table 127. Takeda Company Information
Table 128. Takeda Introduction and Business Overview
Table 129. Takeda Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Takeda Immune Drugs Product
Table 131. Takeda Recent Development
Table 132. 3S Bio Company Information
Table 133. 3S Bio Introduction and Business Overview
Table 134. 3S Bio Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. 3S Bio Immune Drugs Product
Table 136. 3S Bio Recent Development
Table 137. Horizo​​n Therapeutics Company Information
Table 138. Horizo​​n Therapeutics Introduction and Business Overview
Table 139. Horizo​​n Therapeutics Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Horizo​​n Therapeutics Immune Drugs Product
Table 141. Horizo​​n Therapeutics Recent Development
Table 142. Bristol-Myers Squibb (BMS Company Information
Table 143. Bristol-Myers Squibb (BMS Introduction and Business Overview
Table 144. Bristol-Myers Squibb (BMS Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Bristol-Myers Squibb (BMS Immune Drugs Product
Table 146. Bristol-Myers Squibb (BMS Recent Development
Table 147. Astellas Company Information
Table 148. Astellas Introduction and Business Overview
Table 149. Astellas Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Astellas Immune Drugs Product
Table 151. Astellas Recent Development
Table 152. Eli Lilly Company Information
Table 153. Eli Lilly Introduction and Business Overview
Table 154. Eli Lilly Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Eli Lilly Immune Drugs Product
Table 156. Eli Lilly Recent Development
Table 157. Mitsubishi Tanabe Pharma Company Information
Table 158. Mitsubishi Tanabe Pharma Introduction and Business Overview
Table 159. Mitsubishi Tanabe Pharma Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Mitsubishi Tanabe Pharma Immune Drugs Product
Table 161. Mitsubishi Tanabe Pharma Recent Development
Table 162. Biogen Company Information
Table 163. Biogen Introduction and Business Overview
Table 164. Biogen Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Biogen Immune Drugs Product
Table 166. Biogen Recent Development
Table 167. Pfizer Company Information
Table 168. Pfizer Introduction and Business Overview
Table 169. Pfizer Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Pfizer Immune Drugs Product
Table 171. Pfizer Recent Development
Table 172. Sanofi Company Information
Table 173. Sanofi Introduction and Business Overview
Table 174. Sanofi Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. Sanofi Immune Drugs Product
Table 176. Sanofi Recent Development
Table 177. Roche Company Information
Table 178. Roche Introduction and Business Overview
Table 179. Roche Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 180. Roche Immune Drugs Product
Table 181. Roche Recent Development
Table 182. Novartis Company Information
Table 183. Novartis Introduction and Business Overview
Table 184. Novartis Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 185. Novartis Immune Drugs Product
Table 186. Novartis Recent Development
Table 187. Johnson & Johnson (J&J) Company Information
Table 188. Johnson & Johnson (J&J) Introduction and Business Overview
Table 189. Johnson & Johnson (J&J) Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 190. Johnson & Johnson (J&J) Immune Drugs Product
Table 191. Johnson & Johnson (J&J) Recent Development
Table 192. Amgen Company Information
Table 193. Amgen Introduction and Business Overview
Table 194. Amgen Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 195. Amgen Immune Drugs Product
Table 196. Amgen Recent Development
Table 197. Abbvi Company Information
Table 198. Abbvi Introduction and Business Overview
Table 199. Abbvi Immune Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 200. Abbvi Immune Drugs Product
Table 201. Abbvi Recent Development
Table 202. Key Raw Materials Lists
Table 203. Raw Materials Key Suppliers Lists
Table 204. Immune Drugs Market Trends
Table 205. Immune Drugs Market Drivers
Table 206. Immune Drugs Market Challenges
Table 207. Immune Drugs Market Restraints
Table 208. Immune Drugs Distributors List
Table 209. Immune Drugs Downstream Customers
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Immune Drugs Product Picture
Figure 2. Global Immune Drugs Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Immune Drugs Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Immune Drugs Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Immune Boosting Drugs
Figure 6. Global Immune Boosting Drugs Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Immunosuppressant Drugs
Figure 8. Global Immunosuppressant Drugs Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Immune Drugs Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Immune Drugs Sales Market Share by Type in 2022 & 2034
Figure 11. North America Immune Drugs Sales Market Share in Volume by Type in 2022
Figure 12. North America Immune Drugs Sales Market Share in Value by Type in 2022
Figure 13. Europe Immune Drugs Sales Market Share in Volume by Type in 2022
Figure 14. Europe Immune Drugs Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Immune Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Immune Drugs Sales Market Share in Value by Type in 2022
Figure 17. Latin America Immune Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Immune Drugs Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Immune Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Immune Drugs Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Drugs Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Drugs Revenue in 2022
Figure 23. Immune Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Surgery Center
Figure 29. Global Surgery Center Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Global Immune Drugs Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Immune Drugs Sales Market Share by Application in 2022 & 2034
Figure 34. North America Immune Drugs Sales Market Share in Volume by Application in 2022
Figure 35. North America Immune Drugs Sales Market Share in Value by Application in 2022
Figure 36. Europe Immune Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Europe Immune Drugs Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Immune Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Immune Drugs Sales Market Share in Value by Application in 2022
Figure 40. Latin America Immune Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Immune Drugs Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Immune Drugs Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Immune Drugs Manufacturing Cost Structure
Figure 45. Immune Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed